nodes	percent_of_prediction	percent_of_DWPC	metapath
Digoxin—SLCO4C1—Methotrexate—lymphatic system cancer	0.208	0.24	CbGbCtD
Digoxin—SLCO1C1—Methotrexate—lymphatic system cancer	0.146	0.169	CbGbCtD
Digoxin—ABCB11—Vincristine—lymphatic system cancer	0.131	0.151	CbGbCtD
Digoxin—SLCO1B3—Methotrexate—lymphatic system cancer	0.0817	0.0941	CbGbCtD
Digoxin—SLCO1A2—Methotrexate—lymphatic system cancer	0.0505	0.0581	CbGbCtD
Digoxin—SLCO1B1—Methotrexate—lymphatic system cancer	0.0476	0.0548	CbGbCtD
Digoxin—SLC22A8—Methotrexate—lymphatic system cancer	0.0439	0.0506	CbGbCtD
Digoxin—ABCB1—Mitoxantrone—lymphatic system cancer	0.0327	0.0377	CbGbCtD
Digoxin—CYP3A4—Cytarabine—lymphatic system cancer	0.0285	0.0328	CbGbCtD
Digoxin—CYP3A4—Teniposide—lymphatic system cancer	0.028	0.0323	CbGbCtD
Digoxin—ABCB1—Vincristine—lymphatic system cancer	0.0225	0.0259	CbGbCtD
Digoxin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0196	0.0226	CbGbCtD
Digoxin—ABCB1—Methotrexate—lymphatic system cancer	0.0136	0.0157	CbGbCtD
Digoxin—CYP3A4—Vincristine—lymphatic system cancer	0.0135	0.0155	CbGbCtD
Digoxin—Cardiotoxicity—Teniposide—lymphatic system cancer	0.0126	0.102	CcSEcCtD
Digoxin—Electrocardiogram change—Teniposide—lymphatic system cancer	0.0104	0.0837	CcSEcCtD
Digoxin—ATP1B1—Podofilox—Teniposide—lymphatic system cancer	0.00696	1	CbGdCrCtD
Digoxin—Cardiotoxicity—Mitoxantrone—lymphatic system cancer	0.00661	0.0531	CcSEcCtD
Digoxin—Digestion impaired—Fludarabine—lymphatic system cancer	0.00392	0.0315	CcSEcCtD
Digoxin—Sinus bradycardia—Mitoxantrone—lymphatic system cancer	0.00318	0.0255	CcSEcCtD
Digoxin—Necrosis—Carmustine—lymphatic system cancer	0.00214	0.0171	CcSEcCtD
Digoxin—Visual disturbance—Fludarabine—lymphatic system cancer	0.00201	0.0161	CcSEcCtD
Digoxin—Necrosis—Mitoxantrone—lymphatic system cancer	0.00199	0.0159	CcSEcCtD
Digoxin—Drug interaction—Carmustine—lymphatic system cancer	0.00181	0.0145	CcSEcCtD
Digoxin—Drug interaction—Vincristine—lymphatic system cancer	0.00172	0.0138	CcSEcCtD
Digoxin—Gynaecomastia—Carmustine—lymphatic system cancer	0.0015	0.012	CcSEcCtD
Digoxin—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00141	0.0113	CcSEcCtD
Digoxin—Anorexia—Mechlorethamine—lymphatic system cancer	0.00137	0.011	CcSEcCtD
Digoxin—Arrhythmia—Teniposide—lymphatic system cancer	0.00134	0.0107	CcSEcCtD
Digoxin—Visual impairment—Fludarabine—lymphatic system cancer	0.00127	0.0102	CcSEcCtD
Digoxin—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00125	0.0101	CcSEcCtD
Digoxin—Arrhythmia—Fludarabine—lymphatic system cancer	0.00117	0.00943	CcSEcCtD
Digoxin—Cardiac arrest—Vincristine—lymphatic system cancer	0.0011	0.00887	CcSEcCtD
Digoxin—Confusional state—Teniposide—lymphatic system cancer	0.00107	0.00861	CcSEcCtD
Digoxin—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00104	0.00836	CcSEcCtD
Digoxin—Tachycardia—Teniposide—lymphatic system cancer	0.00104	0.00833	CcSEcCtD
Digoxin—Anorexia—Teniposide—lymphatic system cancer	0.00101	0.00814	CcSEcCtD
Digoxin—Necrosis—Methotrexate—lymphatic system cancer	0.000989	0.00794	CcSEcCtD
Digoxin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000987	0.00792	CcSEcCtD
Digoxin—Confusional state—Fludarabine—lymphatic system cancer	0.000942	0.00756	CcSEcCtD
Digoxin—Decreased appetite—Teniposide—lymphatic system cancer	0.000924	0.00742	CcSEcCtD
Digoxin—Vomiting—Mechlorethamine—lymphatic system cancer	0.000917	0.00736	CcSEcCtD
Digoxin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000915	0.00735	CcSEcCtD
Digoxin—Rash—Mechlorethamine—lymphatic system cancer	0.000909	0.0073	CcSEcCtD
Digoxin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000908	0.00729	CcSEcCtD
Digoxin—Anorexia—Fludarabine—lymphatic system cancer	0.000891	0.00715	CcSEcCtD
Digoxin—Feeling abnormal—Teniposide—lymphatic system cancer	0.000876	0.00703	CcSEcCtD
Digoxin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000869	0.00698	CcSEcCtD
Digoxin—Nausea—Mechlorethamine—lymphatic system cancer	0.000857	0.00688	CcSEcCtD
Digoxin—Abdominal pain—Teniposide—lymphatic system cancer	0.00084	0.00675	CcSEcCtD
Digoxin—Hallucination—Carmustine—lymphatic system cancer	0.000837	0.00672	CcSEcCtD
Digoxin—Dyspepsia—Fludarabine—lymphatic system cancer	0.000822	0.0066	CcSEcCtD
Digoxin—Decreased appetite—Fludarabine—lymphatic system cancer	0.000812	0.00652	CcSEcCtD
Digoxin—Visual impairment—Carmustine—lymphatic system cancer	0.000811	0.00651	CcSEcCtD
Digoxin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000807	0.00648	CcSEcCtD
Digoxin—Hallucination—Vincristine—lymphatic system cancer	0.000799	0.00642	CcSEcCtD
Digoxin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00077	0.00618	CcSEcCtD
Digoxin—Asthenia—Teniposide—lymphatic system cancer	0.000763	0.00612	CcSEcCtD
Digoxin—Arrhythmia—Carmustine—lymphatic system cancer	0.000752	0.00604	CcSEcCtD
Digoxin—Cardiac disorder—Vincristine—lymphatic system cancer	0.000746	0.00599	CcSEcCtD
Digoxin—Diarrhoea—Teniposide—lymphatic system cancer	0.000727	0.00584	CcSEcCtD
Digoxin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000699	0.00561	CcSEcCtD
Digoxin—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000695	0.00558	CcSEcCtD
Digoxin—Confusional state—Bleomycin—lymphatic system cancer	0.000691	0.00555	CcSEcCtD
Digoxin—Vision blurred—Carmustine—lymphatic system cancer	0.00069	0.00554	CcSEcCtD
Digoxin—Vomiting—Teniposide—lymphatic system cancer	0.000676	0.00543	CcSEcCtD
Digoxin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000671	0.00539	CcSEcCtD
Digoxin—Asthenia—Fludarabine—lymphatic system cancer	0.00067	0.00538	CcSEcCtD
Digoxin—Rash—Teniposide—lymphatic system cancer	0.00067	0.00538	CcSEcCtD
Digoxin—Dermatitis—Teniposide—lymphatic system cancer	0.00067	0.00538	CcSEcCtD
Digoxin—Headache—Teniposide—lymphatic system cancer	0.000666	0.00535	CcSEcCtD
Digoxin—Anorexia—Bleomycin—lymphatic system cancer	0.000653	0.00524	CcSEcCtD
Digoxin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000642	0.00515	CcSEcCtD
Digoxin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000639	0.00513	CcSEcCtD
Digoxin—Nausea—Teniposide—lymphatic system cancer	0.000631	0.00507	CcSEcCtD
Digoxin—Anxiety—Carmustine—lymphatic system cancer	0.000622	0.00499	CcSEcCtD
Digoxin—Confusional state—Carmustine—lymphatic system cancer	0.000603	0.00484	CcSEcCtD
Digoxin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000595	0.00478	CcSEcCtD
Digoxin—Visual disturbance—Methotrexate—lymphatic system cancer	0.000595	0.00477	CcSEcCtD
Digoxin—Vomiting—Fludarabine—lymphatic system cancer	0.000594	0.00477	CcSEcCtD
Digoxin—Rash—Fludarabine—lymphatic system cancer	0.000589	0.00473	CcSEcCtD
Digoxin—Dermatitis—Fludarabine—lymphatic system cancer	0.000589	0.00473	CcSEcCtD
Digoxin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000585	0.0047	CcSEcCtD
Digoxin—Headache—Fludarabine—lymphatic system cancer	0.000585	0.0047	CcSEcCtD
Digoxin—Tachycardia—Carmustine—lymphatic system cancer	0.000584	0.00469	CcSEcCtD
Digoxin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000578	0.00464	CcSEcCtD
Digoxin—Anorexia—Carmustine—lymphatic system cancer	0.00057	0.00458	CcSEcCtD
Digoxin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000565	0.00453	CcSEcCtD
Digoxin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000561	0.0045	CcSEcCtD
Digoxin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000559	0.00449	CcSEcCtD
Digoxin—Nausea—Fludarabine—lymphatic system cancer	0.000555	0.00446	CcSEcCtD
Digoxin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000544	0.00437	CcSEcCtD
Digoxin—Anorexia—Vincristine—lymphatic system cancer	0.000544	0.00437	CcSEcCtD
Digoxin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000543	0.00436	CcSEcCtD
Digoxin—Anorexia—Mitoxantrone—lymphatic system cancer	0.00053	0.00425	CcSEcCtD
Digoxin—Decreased appetite—Carmustine—lymphatic system cancer	0.00052	0.00417	CcSEcCtD
Digoxin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000516	0.00415	CcSEcCtD
Digoxin—Decreased appetite—Vincristine—lymphatic system cancer	0.000496	0.00398	CcSEcCtD
Digoxin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000493	0.00396	CcSEcCtD
Digoxin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000493	0.00396	CcSEcCtD
Digoxin—Asthenia—Bleomycin—lymphatic system cancer	0.000491	0.00395	CcSEcCtD
Digoxin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000489	0.00393	CcSEcCtD
Digoxin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000489	0.00393	CcSEcCtD
Digoxin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000483	0.00388	CcSEcCtD
Digoxin—Abdominal pain—Carmustine—lymphatic system cancer	0.000473	0.0038	CcSEcCtD
Digoxin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000467	0.00375	CcSEcCtD
Digoxin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000458	0.00368	CcSEcCtD
Digoxin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000455	0.00365	CcSEcCtD
Digoxin—Abdominal pain—Vincristine—lymphatic system cancer	0.000451	0.00362	CcSEcCtD
Digoxin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000439	0.00353	CcSEcCtD
Digoxin—Vomiting—Bleomycin—lymphatic system cancer	0.000436	0.0035	CcSEcCtD
Digoxin—Rash—Bleomycin—lymphatic system cancer	0.000432	0.00347	CcSEcCtD
Digoxin—Dermatitis—Bleomycin—lymphatic system cancer	0.000432	0.00346	CcSEcCtD
Digoxin—Asthenia—Carmustine—lymphatic system cancer	0.000429	0.00344	CcSEcCtD
Digoxin—Asthenia—Vincristine—lymphatic system cancer	0.00041	0.00329	CcSEcCtD
Digoxin—Diarrhoea—Carmustine—lymphatic system cancer	0.000409	0.00329	CcSEcCtD
Digoxin—Nausea—Bleomycin—lymphatic system cancer	0.000407	0.00327	CcSEcCtD
Digoxin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000399	0.0032	CcSEcCtD
Digoxin—Dizziness—Carmustine—lymphatic system cancer	0.000395	0.00317	CcSEcCtD
Digoxin—Diarrhoea—Vincristine—lymphatic system cancer	0.000391	0.00314	CcSEcCtD
Digoxin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00038	0.00305	CcSEcCtD
Digoxin—Vomiting—Carmustine—lymphatic system cancer	0.00038	0.00305	CcSEcCtD
Digoxin—Dizziness—Vincristine—lymphatic system cancer	0.000377	0.00303	CcSEcCtD
Digoxin—Rash—Carmustine—lymphatic system cancer	0.000377	0.00303	CcSEcCtD
Digoxin—Dermatitis—Carmustine—lymphatic system cancer	0.000377	0.00302	CcSEcCtD
Digoxin—Visual impairment—Methotrexate—lymphatic system cancer	0.000376	0.00302	CcSEcCtD
Digoxin—Headache—Carmustine—lymphatic system cancer	0.000375	0.00301	CcSEcCtD
Digoxin—Vomiting—Vincristine—lymphatic system cancer	0.000363	0.00291	CcSEcCtD
Digoxin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000362	0.00291	CcSEcCtD
Digoxin—Rash—Vincristine—lymphatic system cancer	0.00036	0.00289	CcSEcCtD
Digoxin—Dermatitis—Vincristine—lymphatic system cancer	0.00036	0.00289	CcSEcCtD
Digoxin—Headache—Vincristine—lymphatic system cancer	0.000358	0.00287	CcSEcCtD
Digoxin—Nausea—Carmustine—lymphatic system cancer	0.000355	0.00285	CcSEcCtD
Digoxin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000353	0.00284	CcSEcCtD
Digoxin—Rash—Mitoxantrone—lymphatic system cancer	0.000351	0.00281	CcSEcCtD
Digoxin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00035	0.00281	CcSEcCtD
Digoxin—Headache—Mitoxantrone—lymphatic system cancer	0.000348	0.0028	CcSEcCtD
Digoxin—Nausea—Vincristine—lymphatic system cancer	0.000339	0.00272	CcSEcCtD
Digoxin—Nausea—Mitoxantrone—lymphatic system cancer	0.00033	0.00265	CcSEcCtD
Digoxin—Vision blurred—Methotrexate—lymphatic system cancer	0.00032	0.00257	CcSEcCtD
Digoxin—Confusional state—Methotrexate—lymphatic system cancer	0.000279	0.00224	CcSEcCtD
Digoxin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000271	0.00218	CcSEcCtD
Digoxin—Anorexia—Methotrexate—lymphatic system cancer	0.000264	0.00212	CcSEcCtD
Digoxin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000244	0.00196	CcSEcCtD
Digoxin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000241	0.00193	CcSEcCtD
Digoxin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000239	0.00192	CcSEcCtD
Digoxin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000228	0.00183	CcSEcCtD
Digoxin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000226	0.00182	CcSEcCtD
Digoxin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000219	0.00176	CcSEcCtD
Digoxin—Asthenia—Methotrexate—lymphatic system cancer	0.000199	0.0016	CcSEcCtD
Digoxin—Diarrhoea—Methotrexate—lymphatic system cancer	0.00019	0.00152	CcSEcCtD
Digoxin—Dizziness—Methotrexate—lymphatic system cancer	0.000183	0.00147	CcSEcCtD
Digoxin—Vomiting—Methotrexate—lymphatic system cancer	0.000176	0.00141	CcSEcCtD
Digoxin—Rash—Methotrexate—lymphatic system cancer	0.000175	0.0014	CcSEcCtD
Digoxin—Dermatitis—Methotrexate—lymphatic system cancer	0.000174	0.0014	CcSEcCtD
Digoxin—Headache—Methotrexate—lymphatic system cancer	0.000174	0.00139	CcSEcCtD
Digoxin—Nausea—Methotrexate—lymphatic system cancer	0.000165	0.00132	CcSEcCtD
